Tropacocaine

Tropacocaine at a Glance

Tropacocaine, or benzoylpseudotropine, is a minor tropane alkaloid of the coca plant (Erythroxylum). Structurally it is the benzoyl ester of pseudotropine — the 3β tropane amino-alcohol — which makes it a simplified structural relative of cocaine: it carries the benzoate group but lacks the C2 carbomethoxy (methoxycarbonyl) group that cocaine’s ecgonine core adds.

That missing ester is the whole story of the molecule. Cocaine’s strong dopamine/noradrenaline-reuptake blockade — the basis of its stimulant and reinforcing profile — depends on the fuller ecgonine substitution pattern. Tropacocaine keeps only the local-anaesthetic-type side of the tropane-ester repertoire and was historically noted for exactly that: a simple, cocaine-adjacent local anaesthetic ^{4Reference 4Reith ME et al. · 1985AnimalLocomotor effects of cocaine, cocaine congeners, and local anesthetics in miceView study →}.

Today tropacocaine has essentially no modern pharmacology programme. Its practical relevance is chemotaxonomic and analytical — it is one of the roughly 18 identified alkaloids used to characterise and profile Erythroxylum leaf and seed material ^{1,2,5Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 2Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →Reference 5Hegnauer R · 1981Chemotaxonomy of Erythroxylaceae (including some ethnobotanical notes on Old World species)View study →}. This page is scholarly phytochemistry and pharmacology; it is not a use, preparation, or extraction guide.

A Minor Benzoyl-Pseudotropine Coca Alkaloid

The reason tropacocaine earns a page is its position in coca’s alkaloid family and its clean structural contrast with cocaine.

It is pseudotropine, benzoylated. Pseudotropine is the 3β (endo) epimer of tropine — the tropane ring bearing a single hydroxyl in the 3β orientation. Esterify that hydroxyl with benzoic acid and you have tropacocaine. So where cocaine is built on ecgonine (a tropane bearing both a 3β-benzoyloxy group and a 2β-carbomethoxy group), tropacocaine is built on the plain 3β-alcohol and stops after the single benzoate — no C2 ester ^{1Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}.

Why the contrast matters. The 2β-carbomethoxy group is a large part of what makes cocaine a potent monoamine-reuptake inhibitor. Removing it, as in tropacocaine, strips out most of that reuptake-driven stimulant character and leaves a molecule whose measurable actions are dominated by the local-anaesthetic (sodium-channel) behaviour shared broadly across tropane and other local-anaesthetic esters ^{3,4Reference 3Komiskey HL et al. · 1977AnimalThe isomers of cocaine and tropacocaine: effect on ³H-catecholamine uptake by rat brain synaptosomesView study →Reference 4Reith ME et al. · 1985AnimalLocomotor effects of cocaine, cocaine congeners, and local anesthetics in miceView study →}.

Its two real-world roles are historical and analytical. Historically, tropacocaine was regarded as a simpler local anaesthetic in the cocaine mould. In the modern literature it functions chiefly as a marker alkaloid — one of the constituents that analytical and chemotaxonomic surveys track when characterising Erythroxylum species, varieties, and seized material ^{1,2,5Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 2Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →Reference 5Hegnauer R · 1981Chemotaxonomy of Erythroxylaceae (including some ethnobotanical notes on Old World species)View study →}.

What It's Used For

The honest evidence picture is thin. Tropacocaine has never been the subject of a modern therapeutic research programme; the isolate literature is a small set of older comparative-pharmacology papers plus its recurring appearance in coca chemotaxonomy. The evidence splits by whether the point being made is pharmacological (what the molecule does) or analytical (that the molecule is there).

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Note the shape: the best-evidenced row is an analytical role, not a therapeutic one, and every pharmacology row rests on older animal/in-vitro comparisons, never modern human trials.

01Chemotaxonomic / Analytical MarkerShaky32%Recurrent identification among coca alkaloids in leaf/seed chemistry ^{1,2,5Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 2Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →Reference 5Hegnauer R · 1981Chemotaxonomy of Erythroxylaceae (including some ethnobotanical notes on Old World species)View study →}

02Local-Anaesthetic Activity (Sodium-Channel)Shaky22%Older animal pharmacology + historical anaesthetic reputation; no modern isolate data ^{4Reference 4Reith ME et al. · 1985AnimalLocomotor effects of cocaine, cocaine congeners, and local anesthetics in miceView study →}

03Monoamine Reuptake / Stimulant-Type ActivityShaky12%Weak/mostly-negative vs cocaine in catecholamine-uptake comparison ^{3,4Reference 3Komiskey HL et al. · 1977AnimalThe isomers of cocaine and tropacocaine: effect on ³H-catecholamine uptake by rat brain synaptosomesView study →Reference 4Reith ME et al. · 1985AnimalLocomotor effects of cocaine, cocaine congeners, and local anesthetics in miceView study →}

Mechanisms

The load-bearing point is the last row: tropacocaine is “cocaine minus the C2 ester.” Removing that group subtracts most of the reuptake-driven stimulant pharmacology and leaves the shared local-anaesthetic (sodium-channel) behaviour.

Pharmacokinetics

There are no dedicated modern pharmacokinetic data for isolated tropacocaine — absorption, oral bioavailability, metabolism, active metabolites and half-life are uncharacterised. As a benzoate ester of an amino-alcohol, it would be expected to undergo esterase-mediated hydrolysis (to benzoic acid and pseudotropine) in the way other tropane benzoate esters do, but this is structural inference, not measured data for tropacocaine specifically. Because human exposure via coca is as a trace minor alkaloid, no meaningful systemic-exposure figures exist.

Clinical Trials

There are no clinical trials of isolated tropacocaine — none completed, planned or terminated. It is not a clinical entity in modern medicine; its historical anaesthetic use predates the modern trials framework and is not part of current practice. The only human-relevant experimental record is the older animal and in-vitro comparative pharmacology cited here ^{3,4Reference 3Komiskey HL et al. · 1977AnimalThe isomers of cocaine and tropacocaine: effect on ³H-catecholamine uptake by rat brain synaptosomesView study →Reference 4Reith ME et al. · 1985AnimalLocomotor effects of cocaine, cocaine congeners, and local anesthetics in miceView study →}.

Last checked: July 2026.

Prevalence in Nature

Tropacocaine occurs in coca (Erythroxylum), the same plants that produce cocaine, as a minor tropane alkaloid of both leaf and seed ^{1,2Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 2Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}. It is one of the roughly 18 alkaloids identified across cultivated coca varieties, sitting far below cocaine — which runs at about 0.5–1% of leaf dry weight — in abundance ^{1Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}. In the seed of E. coca var. coca it is reported among the native leaf/seed tropanes rather than as an analytical artefact ^{2Reference 2Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}.

Its distribution is variety-dependent: Erythroxylum species and cultivars differ in their minor-alkaloid fingerprints, which is precisely why these tropanes are useful chemotaxonomically ^{5Reference 5Hegnauer R · 1981Chemotaxonomy of Erythroxylaceae (including some ethnobotanical notes on Old World species)View study →}. Historically, tropacocaine was particularly associated with Java-grown coca leaf (of the E. novogranatense lineage), where it was a comparatively conspicuous minor alkaloid. Reliable quantitative figures for tropacocaine’s share of leaf or seed are not well established in the sources here; that gap is logged for a later pass.

Discovery & Synthesis

Tropacocaine belongs to the classical coca-alkaloid chemistry that followed the isolation of cocaine in the mid-nineteenth century, when the minor alkaloids of Erythroxylum leaf were being separated and named; it was historically associated with Java coca leaf, where it stood out among the minor tropanes. Structurally the compound is straightforward to place: it is the benzoate ester of pseudotropine (the 3β tropanol), i.e. cocaine’s skeleton without the C2 carbomethoxy group — which is why early pharmacologists treated it as a simpler, cocaine-adjacent local anaesthetic ^{4Reference 4Reith ME et al. · 1985AnimalLocomotor effects of cocaine, cocaine congeners, and local anesthetics in miceView study →}.

Beyond this structural identity, the first-total-synthesis and modern-manufacture history of tropacocaine is not well documented in the sources reviewed here, and no preparation or extraction detail. What is clear is that tropacocaine’s interest today is as a natural coca alkaloid and analytical marker, not as a manufactured product.

Patents: not yet researched.

Toxicity & Safety

Tropacocaine carries a moderate flag. It is a bona-fide local-anaesthetic-class tropane ester — its measurable pharmacology is sodium-channel conduction block ^{4Reference 4Reith ME et al. · 1985AnimalLocomotor effects of cocaine, cocaine congeners, and local anesthetics in miceView study →} — and local anaesthetics as a class carry recognised CNS and cardiac toxicity when enough reaches the circulation. That places it above a plain trace phytochemical. At the same time, two honest qualifiers apply: exposure from coca is as a trace minor alkaloid, and there is no modern isolate toxicology dataset characterising its potency, safety margin, genotoxicity or reproductive profile. Absence of a toxicology package is not a demonstration of safety.

Safety at a Glance

⚠️ Moderate toxicity

• Not the stimulant actor. Tropacocaine lacks cocaine’s C2 ester and does not reproduce its potent dopamine-reuptake blockade; its behavioural profile is conduction-blocking, not stimulant ^{3,4Reference 3Komiskey HL et al. · 1977AnimalThe isomers of cocaine and tropacocaine: effect on ³H-catecholamine uptake by rat brain synaptosomesView study →Reference 4Reith ME et al. · 1985AnimalLocomotor effects of cocaine, cocaine congeners, and local anesthetics in miceView study →}.
• Local-anaesthetic-class agent. Its established action is sodium-channel block; local anaesthetics of this family carry class CNS/cardiac toxicity concerns at sufficient systemic exposure ^{4Reference 4Reith ME et al. · 1985AnimalLocomotor effects of cocaine, cocaine congeners, and local anesthetics in miceView study →}.
• Company it keeps. It occurs in coca alongside cocaine and other tropanes — the serious pharmacology and legal status of that plant are about those alkaloids, and tropacocaine should be read in that context ^{1Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}.
• No isolate toxicology. There is no dedicated modern safety, genotoxicity or reproductive dataset for purified tropacocaine; the moderate flag is a class-based caution, not a measured hazard profile.

Dosage

There is no established or studied modern human dose for isolated tropacocaine. It is not a supplement and not a current medicine; its historical role as an injected local anaesthetic is not present-day practice, and its occurrence in coca is as a trace minor alkaloid rather than a consumed active. No therapeutic dose has been defined because no current therapeutic use exists, and nothing here should be read as a dosing recommendation.

References

1. Novák M, Salemink CA, Khan I (1984). Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatense. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/6379304/
2. Casale JF, Toske SG, Colley VL (2005). Alkaloid content of the seeds from Erythroxylum coca var. coca. Journal of Forensic Sciences. https://pubmed.ncbi.nlm.nih.gov/16382835/
3. Komiskey HL, Miller DD, LaPidus JB, Patil PN (1977). The isomers of cocaine and tropacocaine: effect on ³H-catecholamine uptake by rat brain synaptosomes. Life Sciences. https://pubmed.ncbi.nlm.nih.gov/916808/
4. Reith ME, Meisler BE, Lajtha A (1985). Locomotor effects of cocaine, cocaine congeners, and local anesthetics in mice. Pharmacology, Biochemistry, and Behavior. https://pubmed.ncbi.nlm.nih.gov/2417262/
5. Hegnauer R (1981). Chemotaxonomy of Erythroxylaceae (including some ethnobotanical notes on Old World species). Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/7242111/